SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:Naina Mohamed, PhD
Sodium-Glucose Linked Transporter 2 (SGLT2) inhibitors such as Dapagliflozin (Farxiga), Canagliflozin (Invokana) and Empagliflozin (Jardiance) are a new class of oral drugs available to treat type 2 diabetes mellitus (Type 2 DM).
SGLT2 Inhibitors (Gliflozins): A New Class of Drugs to treat Type 2 Diabetes:Naina Mohamed, PhD
Sodium-Glucose Linked Transporter 2 (SGLT2) inhibitors such as Dapagliflozin (Farxiga), Canagliflozin (Invokana) and Empagliflozin (Jardiance) are a new class of oral drugs available to treat type 2 diabetes mellitus (Type 2 DM).
Presentation given to our fellowship program about diabetic kidney disease.
2022 update discussing SGLT2i, MRA (e.g. finerenone), health economics and beyond
Diabetes is fast gaining the status of a potential epidemic in India with more than 65 million diabetic individuals currently diagnosed with the disease. Ranked second in the world, the burden of the disease is expected to compound in the years to come. Worryingly, diabetes is now being shown to be associated with a spectrum of complications and to be occurring at a relatively younger age within the country.
It is a known fact that most of the diabetes cases in our country is managed by primary care Physicians(PCP) who have a pivotal role to play in ensuring that diabetes patients receive effective care by practicing evidence based management. This said, the sad fact is that health care providers-primary care and specialists alike are not managing our patients with diabetes as well as we should be.
The complexities of the disease and its association with lot of other medical conditions make the management of diabetes more challenging to the PCPs. Patients feeling of frustration and denial about having the chronic condition often are a challenge to the practitioners in convincing the patients for initiation of treatment. With no clear cut national policy guidelines for management of diabetes, we rely on western guidelines which have certain pitfalls and fallacies in our setting.
The DCCT Landmark Trial
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-term Complications in Insulin Dependent Diabetes Mellitus
Relationship of Metabolic syndrome and cognitive impairment has been discussed. Metabolic causes of Dementia and their reversibility has been discussed.
Presentation given to our fellowship program about diabetic kidney disease.
2022 update discussing SGLT2i, MRA (e.g. finerenone), health economics and beyond
Diabetes is fast gaining the status of a potential epidemic in India with more than 65 million diabetic individuals currently diagnosed with the disease. Ranked second in the world, the burden of the disease is expected to compound in the years to come. Worryingly, diabetes is now being shown to be associated with a spectrum of complications and to be occurring at a relatively younger age within the country.
It is a known fact that most of the diabetes cases in our country is managed by primary care Physicians(PCP) who have a pivotal role to play in ensuring that diabetes patients receive effective care by practicing evidence based management. This said, the sad fact is that health care providers-primary care and specialists alike are not managing our patients with diabetes as well as we should be.
The complexities of the disease and its association with lot of other medical conditions make the management of diabetes more challenging to the PCPs. Patients feeling of frustration and denial about having the chronic condition often are a challenge to the practitioners in convincing the patients for initiation of treatment. With no clear cut national policy guidelines for management of diabetes, we rely on western guidelines which have certain pitfalls and fallacies in our setting.
The DCCT Landmark Trial
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-term Complications in Insulin Dependent Diabetes Mellitus
Relationship of Metabolic syndrome and cognitive impairment has been discussed. Metabolic causes of Dementia and their reversibility has been discussed.
Study of Endothelial Dysfunction in Type 2 Diabetes Mellitusiosrjce
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
Type 2 Diabetes Mellitus: The Concerned Complications and Target OrgansApollo Hospitals
Diabetes has been considered as the most dreaded non-communicable disease consuming the mankind rapidly. WHO has predicted the number of diabetics to be approximately 366 millions by 2030. The disease is characterized by hyperglycemia and the basic symptoms are polyphagia, polydipsia and polyuria. The autoimmune type 1 diabetes represent almost 1% of the total diabetic population, the rest being that of type 2 diabetes (T2D). Type 2 diabetes has been linked to a variety of factors such as heredity, environmental factors, unhealthy eating habits, sedentary lifestyle, stress etc. The uncontrolled hyperglycemia has profound deleterious effects on almost all the organs and results in various cardiovascular disorders, retinopathy, neuropathy, and nephropathy. Recent studies have revealed an array of pulmonary dysfunctions related with T2D ranging from respiratory defects to tuberculosis. Diabetes also predisposes the person to hepatic dysfunctions like NAFLD and HCC and a range of infections at various sites which are difficult to manage. Post-surgical infections are of special interest for subjects with uncontrolled hyperglycemia prior to surgery. Scientists all over the world are revealing different pathways and associated therapies for type 2 diabetes in order to control the pathological effects covering almost whole body physiology.
Strategic Approaches to Age-Related Metabolic Insufficiency and Transition in...InsideScientific
In this webinar, Dr. Dennis Turner delves into dementia syndrome, the metabolic changes that occur, and the importance of proper physiological monitoring of animal models.
Brain metabolism transforms with normal aging, and transient, dynamic metabolic insufficiency may underlie critical progression from aging into dementia syndrome and Alzheimer’s disease (AD). Age-related brain metabolism balances vascular-related substrate supply and transport mechanisms into extracellular space to neurons with cellular metabolic needs and utilization. Dynamic metabolic insufficiency can occur when there is intermittent supply-demand mismatch.
Adequacy of neurovascular coupling to provide sufficient cerebral blood flow (CBF) to meet neuronal demand in vivo in a mouse AD model, compared to aged controls were studied. Dr. Turner’s lab analyzed the response to maximal neuronal metabolic demands, spreading depression and anoxia, using imaging, CBF measurements, and oxygen and glucose levels. These in vivo studies require human-similar anesthesia conditions, through monitoring temperature, blood pressure/pulse oximetry, and respiration, to maintain homeostasis. The lab confirmed abnormal neurovascular coupling in a mouse model of AD in response to these metabolic challenges, showing disruption much earlier in dementia than in equivalently aged individuals. Chronic metabolic treatments could influence dementia syndrome progression.
Diabetes mellitus (DM) refers to a group of common metabolic disorders that share the phenotype of hyperglycemia.
Several distinct types of DM are caused by a complex interaction of genetics and environmental factors.
Depending on the etiology of the DM, factors contributing to hyperglycemia include reduced insulin secretion, decreased glucose utilization, and increased glucose production.
The metabolic dysregulation associated with DM causes secondary pathophysiologic changes in multiple organ systems that impose a tremendous burden on the individual with diabetes and on the health care system.
Here is a copy of the presentation that I gave to MRC CBU at Cambridge University on the 5th July 2017, essentially a summary of a book chapter of mine to be published later this year. The focus of my presentation was on connections between #self, #other and our #connections with the environment.
Diabetic Retinopathy: Role of Traditional Medicinal Plants in its management ...inventionjournals
The objective of this review is Diabetic Retinopathy (DR) and Role of herbal medicines for the treatment of DR. Eye is unique structure of the body and its anatomical and physiological framework is said to be unique. Every organism has adaptive capacity to lead life on earth. Due to modern life style, the number of diseases increasing day by day. Diabetic Retinopathy is an ocular manifestation of the systemic disease and sight-threatening disease. The treatment of modern system of medicine, focal laser therapy, anti-vascular growth factor drugs. These treatment modalities have side effects. Various medicinal plants have been studied and shown to be effective in the management of DR.based on a various biomarkers present in them.
Similar to Type 2 Diabetes and Dementia: What's the link? A Review of the Metabolic and Vascular Contributors (20)
This presentation provides a better understanding of the biologic REALities and impact of weight bias on pediatric obesity management. The paradigm shift in pediatric obesity management is also explored, with a review of Health At Every Size (HAES) and the use of the Edmonton Obesity Staging System to help guide management.
Les ulcères du pied et les risques d’amputation des extrémités inférieures ont été identifiés comme sujet prioritaire pour le Comité d’experts des soins du pied diabétique de Champlain. Par conséquent, le Comité d’experts des soins du pied diabétique de Champlain a été établi afin de développer une « boîte à outils », un module de formation et une stratégie d’évaluation des meilleures pratiques pour appuyer l’adoption des meilleures pratiques afin de réduire les ulcères et les amputations du pied pour les personnes vivant avec le diabète dans la région de Champlain. La boîte à outils reflète plusieurs éléments des lignes directrices des meilleures pratiques de l’AIIO et comprend des documents et des ressources pour les fournisseurs de soins et pour les patients tels que les documents fondés sur des données probantes
More from Champlain Regional Coordination Centre (13)
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Type 2 Diabetes and Dementia: What's the link? A Review of the Metabolic and Vascular Contributors
1. Type 2 Diabetes and Dementia: What’s the link? A Review of the Metabolic and Vascular Contributors
Carol Greenwood
Professor, Dept Nutritional Sciences
University of Toronto
Senior Scientist, Rotman Research Institute
Baycrest
2. THANK YOU!
Nicole Anderson
Brad MacIntosh
Michael Chui
Jyotika Desai
Liesel-Ann Meusel
Yanni Papanikolaou
Ekaterina Tchistiakova
William Yuen
Noah Koblinsky
Andrea Maione
Malcolm Binns
Jon Ween
Simon Graham
Jeremy Gilbert
David Jenkins
Sid Feldman
RESEARCH PARTICIPANTS!!!
3. Goals of the Presentation
To understand the impact of T2DM on cognitive function and dementia risk
To explore metabolic and vascular mechanisms which contribute to this risk
To look at the impact of CHO intake on cognitive function
4. Cognition in Type 2 Diabetes
T2DM associated with modest cognitive decrements that evolve slowly over time (Reijmer et al., 2010, 2011)
Middle aged adults – decrements are modest and reasonably confined to specific cognitive functions (Ryan & Geckle, 2000; Ruis et al., 2009)
Older adults – decrements more predominant and widespread, impacting more cognitive functions
Primarily occurring in areas of processing speed, attention, executive function (van den Berg et al., 2010; Yueng et al., 2009)
Meusel LC, et al. Frontiers in Aging Neuroscience 6, article 148. 2014. doi: 10.3389/fnagi.2014.00148.; Meusel LC, et al. J Curr Clin Care 2012; 2(1):6-16.
5. Risk Factors for Decrements on Measures of Information Processing Speed in T2DM
Taken from: Reijmer et al, Diabetes/Metab Res Rev. 26:507-519, 2010
In pooled analyses, across three studies, both higher HbA1c and presence of macrovascular disease are associated with increased risk for poorer information processing speed
6. Decrements Are More Predominant and Widespread in Older Adults with T2DM
Taken from: Reijmer et al, Diabetes/Metab Res Rev. 26:507-519, 2010
7. Translates Into Increased Dementia Risk
Beyond the age of 65 years, T2DM conveys the highest risk for progression to dementia: a 6-8% increased risk relative to those who do not have T2DM
This is over and above that associated with hypertension, dyslipidaemia, and obesity
Associates with both vascular dementia and Alzheimer Disease
8. Vascular Factors Increase Both Stroke and Dementia Risk
Hypertension
Diabetes
High Cholesterol
Smoking
Adopted from Goldestein et. al, Stroke 2006
9. Is the increased dementia risk with T2DM SOLELY explained by its contribution to vascular dysfunction, or are there other contributing T2DM- associated factors?
10. Type 2 Diabetes and Vascular Complications
In addition to hypertension and dyslipidemia, hyperglycemia seems to be an important factor resulting in:
Global decreases in cerebral blood flow
Decreased blood vessel dilation in response to vasodilatory stimuli
Structural changes in the vessel wall that result in atherosclerotic plaque formation.
Presence of cerebrovascular disease associated with a 2-5 fold increase in stroke occurrence, implicated in dementia
11. Hyperglycemia and Vascular Complications
Hyperglycemic-induced reductions in the vasodilator nitric oxide (NO) and increases in the vasoconstrictor endothelin-1 impair dilation of blood vessels. Over time, this results in structural changes in the vessel wall that result in atherosclerotic plaque formation.
adapted from: Meusel et al., J Curr Clin Care 2012; 2(1):6-16.
12. But…..
It is now acknowledged that other metabolic disturbances in T2DM are equally harmful to brain health and function.
13. tau pathology
inflammation
neurovascular dysfunction
microglial activation & reactive gliosis
demyelination & hypermetabolism
oxidative
stress
type 2 diabetes
adapted from: Meusel et al., J Curr Clin Care 2012; 2(1):6-16.
Type 2 Diabetes: A Compromised Brain
increased production of Aβ
Aβ aggregation
neuronal dysfunction
white matter damage
atrophy
cognitive impairment, dementia risk including Alzheimer’s disease
vascular damage
metabolic disruption
•
hyperglycemia
•
insulin resistance
•
altered insulin signalling
•
AGE production
•
HPA axis dysfunction
14. Our Recent Study: Neurocognitive Correlates of Hypertension and Type 2 Diabetes
GOAL: to understand how brain structure and function is impacted in individuals with T2DM and how these changes impact neuropsychological test performance
Participants:
control group: older adults with hypertension
patient group: older adults with hypertension AND T2DM
Exploring the ADDED effect of T2DM, over and above that associated with hypertension
15. Participant Demographics
17 cognitively intact older adults with hypertension versus 13 older adults with hypertension and T2DM
•
age: 72.2 (5.7)
•
education: 15.6 (2.9)
•
duration of hypertension (years): 10.2 (6.7)
•
duration of T2DM (years; n = 13): 11.2 (6.8)
Health status of participants:
•
insulin levels, triglycerides, HDL cholesterol, BMI, waist circumference, and diastolic blood pressure did not differ based on T2DM status
16. T2DM Group Had Higher HbA1c, But Lower Systolic Blood Pressure and Plasma LDL Levels Relative to Hypertension Only Group
Hypertension Only
Hypertension and T2DM
HbA1c (%)
5.7 ± 0.3
6.9 ± 0.5*
Systolic Blood Pressure
139 ± 16
126 ± 16*
LDL Cholesterol
2.9 ± 0.9
1.8 ± 0.6*
* Significantly different from the hypertension only group.
17. Study Design
behavioural
neuropsychological test battery
structural imaging
cortical thickness **
functional imaging
breath-hold task **
episodic memory task
working memory task
** work conducted by:
Ekaterina Tchistiakova, PhD. candidate
Supervisor: Dr. Brad MacIntosh, Sunnybrook Research Institute
18. Previous Structural Imaging Work in T2DM
greater whole brain atrophy (Kamiyama et al., 2010)
smaller total brain volume, larger peripheral CSF volume, increased lateral ventricle volume over time (deBresser et al., 2010)
increased progression of brain atrophy over 3 years (van Elderen et al., 2010)
prefrontal atrophy associated with poorer glycemic control (Bruehl et al., 2009)
Regional and whole brain atrophy associated with poorer performance on measures of global cognitive function and a variety of specific cognitive tasks (van Elderen et al., 2010; Bruehl et al., 2009; Hayashi et al., 2011)
diabetic old
healthy old
19. T2DM Effects on Cerebrovascular Health Which Are Independent of Hypertension
reduced cerebral autoregulation (Brown et al., 2008; Kim et al., 2008) and brain vasodilation response (Last et al., 2007)
reduced regional cerebral blood flow and reactivity (Last et al., 2007)
decreased blood flow velocity, increased cerebrovascular resistance, impaired reactivity (Novak et al., 2006)
21. No Difference in Hippocampal Volumes in Older Adults with Hypertension (HO) vs. Hypertension and T2DM (DO)
Right Hippocampus Left Hippocampus
Volume (mm3)
0
500
1000
1500
2000
2500
3000
HO
HO
DO
DO
22. Structural MRI: Cortical Thickness
Dale et al., 1998
= distance between the white matter surface and pial surface
white matter-grey matter border (WM/GM border)
grey matter-CSF border (pial surface)
pial surface
WM/GM border
24. Relative to older adults with hypertension, those with hypertension and T2DM have decreased cortical thickness and reduced cerebrovascular reactivity
Tchistiakova et al,
NeuroImage: Clinical,
5:36-41, 2014.
25. Decreased cortical thickness was associated with poor performance on executive function tasks
Tchistiakova et al,
NeuroImage: Clinical,
5:36-41, 2014.
26. Study Design
behavioural
neuropsychological test battery
structural imaging
cortical thickness
functional imaging
breath-hold task
episodic memory task
working memory task **
** work conducted by:
Dr. Liesel-Ann Meusel, PDF and William Yuen, M.Sc.
27. Previous Functional Imaging Work in T2DM
resting-state fMRI (Zhou et al., 2010): reduced functional connectivity between hippocampus and:
posterior cingulate
precuneus
medial frontal cortex
anterior cingulate
inferior parietal lobule
28. Brain Regions Activated During Task Performance
Brain Regions Which Are Deactivated During Task Performance (Default Mode)
29. Preliminary Results
Changes to the default mode network
Ability to activate regions associated with task performance
30. Practice Considerations
Need to help individuals manage both their glycemic control as well as other common co-morbid conditions, including hypertension and dyslipidemia
While cognitive deficits will not be highly prevalent in younger adults, with aging, they could become more apparent
Susceptibilities to metabolic dysregulation can even be seen at the meal-to-meal level
31. Glucose and Cognition in Adults
4681012YoungSeniorsPlaceboGlucose
Hall et al, 1989
Neuropsychologia: 27: 1129
(18-23 y)
(58-77 y)
# Scoring Units Recalled
Paragraph Recall
*
32. Consumption of Simple CHO Foods Impairs Delayed Recall in Adults With T2DM
0
2
4
6
8
# of Scoring Units Recalled
Paragraph Recall
0
2
4
6
Word List Recall
# of Words Recalled
Water
Food
Greenwood et al, 2003
Diabetes Care 26:1961
*
33. Low- Versus High- Glycemic Index CHOs In Adults With Type 2 Diabetes
IMM-1IMM-2IMM-3DEL-1DEL-2 No. of words recalled 246810121416Water Bread Pasta abagAUC0200400600800 No. of words recalled 024681012
Word List Recall
Papanikolaou et al, 2006
Diabetologia 49:855
Would have anticipated comparable differences in insulin responses to food ingestion
Time (min) 020406080100120140 Blood Glucose (mmol/L) 6789101112Water Bread Pasta acbbacabc
34. Plasma Glucose, Insulin and Salivary Cortisol Following Macronutrient Drinks in Adults with Type 2 Diabetes
GlucoseTime (mins) 020406080100 Plasma Glucose (mmol/L) 81012141618Glucose Protein Fat Water InsulinTime (mins) 020406080100 Plasma Insulin 101520253035CortisolTime (mins) 020406080100 Cortisol ug/dL 0.0040.0050.0060.007
Desai & Greenwood, in preparation
35. Postprandial Cortisol Predicts Decrements in Paragraph Recall Performance in Adults with Type 2 Diabetes
Desai & Greenwood, in preparation
Paragraph RecallParagraph 1 RecallImmediate Delay 1Delay 2 Units of Information Recalled 4812162024Glucose Protein Fat Water aabbaa,baabba,ba,bCortisol Results in Verbal Memory DecrementsChange in Cortisol-0.2-0.10.00.10.2 Change in Units Recalled on Para 1 Delay 2 -10-5051015p=0.04
36. Improved Performance Following Antioxidant Vitamins in Adults with Type 2 Diabetes
0
2
4
6
8
10
Treatment
Water
Food
Food + Vitamins
0
2
4
6
8
10
12
14
Treatment
Water
Food
Food + Vitamins
Word List Recall
ab
b
a
# Words Recalled
Digit Span
a
b
a
Chui & Greenwood, 2008
Nutrition Research 28:423
37. Memory Deficits in Type 2 Diabetes Associated with Meal Ingestion
Food Ingestion
Insulin Levels
Glucose Levels
Cortisol Levels
Decrements in Hippocampal Function
Oxidative Stress
Inflammatory
Cytokines
38. Conclusions
T2DM is associated with increased risk for cognitive decline and dementia
Both vascular and metabolic complications of T2DM and other common co-morbid disorders are involved
T2DM-associated changes can be observed in brain structure, cerebrovascular health and blood perfusion, and neural activity
Treatment needs to focus across all co-morbid conditions as they all appear to contribute in their own right
Minimizing glucose excursions and metabolic stress may help in sustaining cognitive function throughout the day